133 related articles for article (PubMed ID: 38450511)
1. Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of Hypothyroidism.
Taebnia N; Lauschke VM
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1098-1100. PubMed ID: 38450511
[No Abstract] [Full Text] [Related]
2. LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase.
Wu L; Soundarapandian MM; Castoreno AB; Millar JS; Rader DJ
Circ Res; 2020 Sep; 127(8):1112-1114. PubMed ID: 32808882
[No Abstract] [Full Text] [Related]
3. Angiopoietin-like 3: An important protein in regulating lipoprotein levels.
Burks KH; Basu D; Goldberg IJ; Stitziel NO
Best Pract Res Clin Endocrinol Metab; 2023 May; 37(3):101688. PubMed ID: 35999139
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
DiDonna NM; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
[TBL] [Abstract][Full Text] [Related]
5. Hepatic ER stress suppresses adipose browning through ATF4-CIRP-ANGPTL3 cascade.
Lv S; Zhou Y; Chen J; Yuan H; Zhang ZN; Luan B
Cell Rep; 2022 Sep; 40(13):111422. PubMed ID: 36170814
[TBL] [Abstract][Full Text] [Related]
6.
Pennisi G; Maurotti S; Ciociola E; Jamialahmadi O; Bertolazzi G; Mirarchi A; Bergh PO; Scionti F; Mancina RM; Spagnuolo R; Tripodo C; Boren J; Petta S; Romeo S
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1086-1097. PubMed ID: 38385290
[TBL] [Abstract][Full Text] [Related]
7. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
[TBL] [Abstract][Full Text] [Related]
8. Undaria pinnatifida soluble fiber regulates Angptl3-LPL pathway to lessen hyperlipidemia in mice.
Xiao HB; Lu XY; Zhang HB; Sun ZL; Fang J
J Physiol Biochem; 2013 Dec; 69(4):719-25. PubMed ID: 23595961
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like 3 inhibition and the liver: less is more?
Oostveen RF; Hovingh GK; Stroes ESG
Curr Opin Lipidol; 2023 Dec; 34(6):267-271. PubMed ID: 37820081
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of 3,4,5,6-tetrahydroxyxanthone on dyslipidemia in apolipoprotein E-deficient mice.
Xiao HB; Sun ZL; Lu XY; Li DZ; Xu JP; Hu YP
Can J Physiol Pharmacol; 2008 Dec; 86(12):815-26. PubMed ID: 19088802
[TBL] [Abstract][Full Text] [Related]
12. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.
Barchetta I; Cimini FA; Chiappetta C; Bertoccini L; Ceccarelli V; Capoccia D; Gaggini M; Di Cristofano C; Della Rocca C; Silecchia G; Leonetti F; Lenzi A; Gastaldelli A; Cavallo MG
Liver Int; 2020 Sep; 40(9):2139-2147. PubMed ID: 32510837
[TBL] [Abstract][Full Text] [Related]
13. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
14. ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression.
Li G; Lu D; Wang J; Yue S; Tan M; Liu M; Gao X
Lipids Health Dis; 2022 Sep; 21(1):90. PubMed ID: 36123608
[TBL] [Abstract][Full Text] [Related]
15. Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism.
Yang L; Yin R; Wang Z; Wang X; Zhang Y; Zhao D
Biomed Res Int; 2019; 2019():3814687. PubMed ID: 31380419
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis.
Wang Q; Oliver-Williams C; Raitakari OT; Viikari J; Lehtimäki T; Kähönen M; Järvelin MR; Salomaa V; Perola M; Danesh J; Kettunen J; Butterworth AS; Holmes MV; Ala-Korpela M
Eur Heart J; 2021 Mar; 42(12):1160-1169. PubMed ID: 33351885
[TBL] [Abstract][Full Text] [Related]
17. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
[TBL] [Abstract][Full Text] [Related]
18. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH
J Lipid Res; 2015 Jul; 56(7):1296-307. PubMed ID: 25954050
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL3 as therapeutic target.
Kersten S
Curr Opin Lipidol; 2021 Dec; 32(6):335-341. PubMed ID: 34581310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]